Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.54, $0.17 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $5.74 billion versus the consensus estimate of $5.91 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2020 EPS of $7.20-$7.40, versus the consensus of $7.28.

• The company has updated certain elements of its 2020 financial guidance to reflect management's current expectations for underlying business performance.
• Earnings per share for 2020 are now expected to be in the range of $6.20 to $6.40 on a reported basis and are still expected to be in the range of $7.20 to $7.40 on a non-GAAP basis.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.